Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 06, 2026
TickeronGET DAILY SIGNALS
Why Is Sonida Senior Living (SNDA) Stock Down -3.96% Today?

Why Is Sonida Senior Living (SNDA) Stock Down -3.96% Today?

Key Takeaways

  • SNDA shares were down roughly 3.96% in Thursday's session, extending the sharp sell-off that followed its third-quarter earnings report.
  • Primary catalyst: Continued post-earnings selling after the company posted a wider-than-expected quarterly loss and offered no formal 2027 guidance.
  • Secondary drivers: Sequential deceleration in key operating metrics, elevated net leverage, and shareholder dilution tied to the CHP merger.
  • Broader context: The move reflects a re-rating of high-growth senior housing names amid questions about the pace and cost of portfolio integration.
  • What to watch next: Fourth-quarter results, 2027 guidance, CHP integration milestones, and acquisition deployment totals.
  • Get deeper analysis on Price Targets, Earnings, and Forecast for this stock.
  • Explore the strongest performers under current market conditions on Tickeron's Trending AI Robots page.

Opening Summary

Sonida Senior Living, Inc. (SNDA), a Dallas-based owner and operator of senior living communities, saw its stock extend losses on Thursday, trading down about 3.96% to $32.71. The decline followed Wednesday's close of $34.06, adding to a post-earnings pullback that began when the company reported third-quarter results. Sonida owns, manages, or is invested in roughly 165 senior housing communities with more than 16,400 units across 35 states, spanning independent living, assisted living, and memory care. The continued selling reflects investor unease over a mixed quarterly print, slower sequential operating momentum, and a lack of formal forward guidance.

Earnings Miss and Guidance Gap

The immediate backdrop to the move is the company's third-quarter report. Sonida posted a net loss attributable to common shareholders of $34.3 million, or $0.72 per share, which missed analyst expectations on the bottom line. Revenue, by contrast, came in above consensus at $210.2 million, more than double the prior-year figure, driven largely by the CHP Healthcare Properties merger that closed in March. The disconnect between a top-line beat and a bottom-line miss has left investors focused on the quality of growth and the costs of integration, including elevated transaction, transition, and stock-based compensation expenses. Management also indicated it would not provide formal full-year 2027 guidance until fourth-quarter results, leaving the stock without a concrete near-term roadmap.

Sequential Deceleration and Rising Leverage

Beneath the headline numbers, several operating trends cooled on a sequential basis. Same-store weighted average occupancy reached 88.6%, up 200 basis points year over year, and same-store net operating income grew 15.6% with margin expansion of 230 basis points to 31.8%. However, same-store NOI growth slowed from the prior quarter, revenue per occupied unit growth eased to 4.6%, and the same-store margin slipped modestly versus the second quarter. Net leverage also climbed to 8.1 times from 7.8 times at the end of June, well above the company's stated 6.0-to-6.5 times target. These dynamics have reinforced caution about how efficiently the enlarged portfolio is converting growth into per-share value.

Dilution and Integration Costs Weigh on Sentiment

Shareholder dilution remains a central concern. Weighted average shares outstanding rose to roughly 47.6 million from 18.1 million a year earlier, a product of the CHP merger and subsequent equity issuance. As a result, robust absolute-dollar revenue growth has translated less efficiently to earnings per share. While management highlighted a record acquisition deployment pace of about $250 million for 2026 and progress transitioning CHP communities onto its platform, the lingering costs of integration and the heavy use of equity to fund growth have tempered enthusiasm. Investors appear to be demanding clearer evidence that the combined company can deliver sustained margin and leverage improvement.

Market Context and Trading Activity

Trading activity has been elevated relative to recent sessions as investors continue to digest the quarterly results, with turnover well above the stock's typical daily pace. The weakness has coincided with a broader reassessment of senior housing operators, where growth stories are being scrutinized for the durability of occupancy and rate momentum. The move also reflects the stock's own technical setup: after a strong run into earnings, shares have now broken below near-term support levels, compounding the fundamental-driven selling pressure.

What Comes Next for SNDA

Looking ahead, traders will focus on the company's fourth-quarter results and the formal 2027 guidance expected to accompany them. Key watch items include the pace of CHP community transitions, whether same-store occupancy and NOI growth stabilize or continue to decelerate, and progress toward the company's leverage targets. The completion of roughly $250 million in 2026 acquisition deployment and the integration of recently acquired operators will also shape sentiment. Risks include seasonal operating softness, elevated interest costs, and continued shareholder dilution if equity remains the preferred funding tool. Until clearer forward guidance arrives, the stock is likely to remain sensitive to both operating data and broader sector sentiment.

Trending AI Robots

Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a range of systematic approaches to monitor. Explore the Trending AI Robots page to see which automated strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SNDA

SNDA sees its Stochastic Oscillator climbs out of oversold territory

On October 30, 2026, the Stochastic Oscillator for SNDA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 65 instances where the indicator left the oversold zone. In 54 of the 65 cases the stock moved higher in the following days. This puts the odds of a move higher at over 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SNDA's RSI Oscillator exited the oversold zone, 20 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on SNDA as a result. In 73 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for SNDA just turned positive on October 30, 2026. Looking at past instances where SNDA's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.

Following a +9.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNDA advanced for three days, in 201 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

SNDA moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

SNDA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNDA entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating fairly steady price growth. SNDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.899) is normal, around the industry mean (203.977). P/E Ratio (-6.007) is within average values for comparable stocks, (20.904). SNDA's Projected Growth (PEG Ratio) (16.640) is very high in comparison to the industry average of (2.498). Dividend Yield (0.000) settles around the average of (0.097) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.47B. The market cap for tickers in the group ranges from 20.9K to 109.87B. HCA holds the highest valuation in this group at 109.87B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 12%. AGL experienced the highest price growth at 32%, while NIVF experienced the biggest fall at -57%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 24%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 46
Price Growth Rating: 48
SMR Rating: 66
Profit Risk Rating: 82
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of senior living communities

Industry HospitalNursingManagement

Industry
Hospital Or Nursing Management
Address
14755 Preston Road
Phone
+1 972 770-5600
Employees
5140
Web
https://www.sonidaseniorliving.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition. Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.
ExxonMobil reported GAAP net earnings of $4.2 billion, or $1.00 per diluted share (EPS), down from $7.7 billion, or $1.76 per share, in Q1 2025. Adjusted earnings excluding identified items reached $4.9 billion, or $1.16 per share, surpassing consensus estimates around $1.00 to $1.07.